chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I have had several Hospital Admissions of people who had prior documented COVID 19 infections that then receive the Vaccine after they recovered and then have an inflammatory reaction that is similar to prior symptoms they suffered during their COVID 19 infection.
Severe vertigo for 48+ hours. Dizziness continued for seven days. Tinnitus and hearing loss. Suspected case of labyrinthitis.
Patient has swelling and redness at the site of administration on upper arm. No pain or itching. Patient has visited a doctor for that and given some medication. They are monitoring the patient.
Was attempting to take the needle cap off the needle and  the syringe broke just under the base of the top of the vaccine syringe. Snapped completely off.  NDC:49281-400-89 LOT: U7665BA EX: 04MAR25
Received vaccine 6/11/13 before discharge from hospital. Several hours later (while still in hospital) developed rash on (L) hand and on chin. Later that night at home after discharge rash on chin and hand became bumpy, red, and itchy. Redness on arms, back, buttocks, belly with itching. To take BENADRYL PO, contact precautions.
pt recv vax 20MAR98 & exp nausea, aching in muscles, discomfort, h/a;
It is currently 36 hours since I first started a reaction to the bug bite and the conditions persist.
cellulitis vs reative inflammation in rt upper arm;6cm reddened area, warm to touch, hard near inj site;
Swollen lymphnodes in left side of the neck; An acceleration in her heart rate; Twinges of pain in her chest; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (An acceleration in her heart rate), CHEST PAIN (Twinges of pain in her chest) and LYMPHADENOPATHY (Swollen lymphnodes in left side of the neck) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced TACHYCARDIA (An acceleration in her heart rate) and CHEST PAIN (Twinges of pain in her chest). On 22-Feb-2021, the patient experienced LYMPHADENOPATHY (Swollen lymphnodes in left side of the neck). On 17-Feb-2021, TACHYCARDIA (An acceleration in her heart rate) and CHEST PAIN (Twinges of pain in her chest) had resolved. At the time of the report, LYMPHADENOPATHY (Swollen lymphnodes in left side of the neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Swollen left middle finger with redness and sensitivity to touch. Saw Dr 04/05/2021. Suspected at the time cellulitis. Treated with Bactrim antibiotics. Noticed vision issues 04/09/2021. Assumed due to lack of sleep previous week.
This case was reported by a other health professional via call center representative and described the occurrence of injection site redness in a 4-year-old female patient who received KINRIX (batch number 2AG24, expiry date 10th September 2017). On 27th March 2017, the patient received KINRIX (intramuscular) .5 ml. In March 2017, less than a week after receiving KINRIX, the patient experienced injection site redness, injection site swelling, injection site warmth and injection site tenderness. On 27th March 2017, the patient experienced vaccine administered at inappropriate site. The patient was treated with ibuprofen and non-drug therapy (Warm Compress). On an unknown date, the outcome of the injection site redness, injection site swelling, injection site warmth, injection site tenderness and vaccine administered at inappropriate site were unknown. It was unknown if the reporter considered the injection site redness, injection site swelling, injection site warmth and injection site tenderness to be related to KINRIX. Additional details were provided as follows: This case was previously reported to a doctor. This case was reported by a medical assistant. The patient received KINRIX vaccine as a 5th DTAP and 4th IPV dose in right thigh, which led to an inappropriate site of vaccination. Two days after vaccination, the patient's mother contacted the physician office and reported redness, swelling, warmth and tenderness at the injection site. The patient was seen by the physician the day before reporting date also and recommended to take ibuprofen and follow up on the next day. The warm compresses might be recommended if needed, as determined by the symptoms at that time.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 16Sep2022 as dose 3 (booster), single (Lot number: Gh9094) at the age of 61 years, in right arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 29Oct2021 as dose 2, single (Lot number: Paa165969), in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient has no known allergies. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 including Paxlovid treatment on 19Jan2023 to 24Jan2023.
I was fine at 10:45 while making breakfast but suddenly at 11am I had to lay down without eating.  Body aches started by 11:15am.  At 11:30am my whole body started shaking uncontrollably and I felt freezing cold. I could tell I was fevering and alternated between Advil and Tylenol starting at noon. By 4pm my eyes hurt so bad if I closed them and my eye lids hurt if I opened my eyes I couldn't eat because my throat and stomach hurt so bad and I couldn't hold a fork or spoon.  I continued to drink a LOT of water but that was all I could do. My husband said I was burning up more than he has ever seen me and I was shaking so hard you could feel it if you stood anywhere in the room of the couch I was laying on.  At about 5pm my thighs started hurting from my pants so I had to change into my loosest pants possible. When I did I notice my thighs were bright red (I'm guessing it's similar to when my husband has a gout flair up). Because I was so cold I laid under 4 blankets in addition to wearing 4 layers. I tried a warm (not hot) bath but moving hurt so much I needed my husband to help me out of the tub and to get dressed again. By 6pm inside my ears hurt and moving my eyes at all was very painful. This all lasted until about 11pm. Then the shaking slowed down and the fever reduced. I was finally able to sleep. In the morning my body was exhausted but functional. No fever and I was able to eat a light meal.  The day after that I was still tired but not bad. No other side effect except my thighs ended up bruised for about a week.
MIGHT NOT BE LINKED TO VACCINE but, please, watch for Bacterial Endocarditis following Covid vaccinations. On-set following vaccination seems suspicious but might be coincidental. He died of Bacterial Endocarditis on May 6, 2020. First weird symptoms began March 10, very slight chills after going out for a walk. He had had pretty strong flu-like symptoms began 4 1/2 days after first vaccine  dose and lasted 5  1/2 to 6 days (we reported to CDC and Moderna). Then he felt great for 3 days, then weird little symptoms began. Please,  just put in data base to look for trends. He most likely had a very very mild case of Covid in early to mid February 2020. Lasted 3 days with fatigue and diarrhea only.   Thank you very much
Eyes swollen, red swollen thighs, went to ER - they instructed Mom it was a reaction to her shots.
redness, swelling, itchiness, tenderness, pain, warm to touch began immediately and lasted for a couple days after vaccination
Red, papular, vesicular, asymptomatic chin, upper/lower extremities left ear very red, swollen 2/7/09
PATIENT HAS BEEN EXPERIENCING QUITE A BIT OF MUSCLE PAIN SINCE RECEIVING SHOT. SHE FEELS LIKE SHE CAN HARDLY MOVE THE ARM (EVEN WITH ROUTINE DAILY EVENTS LIKE DRESSING OR LIFTING OBJECTS). SHE STATES SHE FEELS A KNOT IN HER ARM.
From initial information received on 05/18/2004 from a healthcare professional regarding an adverse event occurring in the USA, it was reported that a 29 year old male patient received a TD Adult vaccination, lot number U1018BA, administered intramuscularly in the right deltoid on 01/18/2004.  Approximately ten days after vaccination the patient became lethargic, dizzy, tired and developed generalized muscle twitching.  The patient's recovery status is currently unknown.  From information received on 08/09/2004 from the initial reporter, the case was reviewed and there was no additional medical information at this time.  It was not reported whether the patient recovered from these events.
Nausea - approximately 5-10 minutes after getting the shot - still feel nauseated when he reported the side effect (already more than 3 hours) and feel a little warm.
Severe itching, welts, and pain over a large portion of my body.  Ice, Cortisone creme with benadryl were applied to affected areas.  Benadryl and tylanel were administered.
received PENTACEL and had a reaction to the DTaP component; big knots on her legs; Initial information received  on 16-Jun-2022 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 9 months old female patient who experienced received Pentacel and had a reaction to the dtap component and big knots on her legs while receiving vaccine diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine [Pentacel].   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, tetanus vaccine toxoid (infanrix) for Prophylactic vaccination.  On an unknown date, the patient received a dose of suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine (strength, dose, formulation, route, lot number: not reported) in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious event received pentacel and had a reaction to the dtap component (reaction to previous exposure to any vaccine) and big knots on her legs (skin mass) (unknown latency) following the administration of diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the events.  At time of reporting, the outcome was Unknown for both the events.
None- vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details reported.  No treatment details reported.   This case was linked to MOD-2021-395985 (Patient Link).
Patient was administered a vaccine that had a refrigerated expiration date of 3/17/2023, and manufacturer expiration date of 1/31/2024. No known harm came to patient and patient did not have an adverse reaction.
2 days after receiving the Janssen vaccine, pt begain with pruritus. No visible marks, no changes in meds or health or diet. Scratching body to point of significant scratch marks and scabs. Also multiple ecchymotic sites on body, some at sight of scratch marks, others scattered. Continues to today w the pruritus and bruising.
Left arm redness; warmth surrounding it; tender - applying ice & taking NSAIDS.
Information has been received from a healthcare worker referring to an unspecified number of patients of unknown age and gender. On unknown dates these patients were vaccinated with doses of improperly stored oral, ROTATEQ (Lot# L020861 with expiration 25-JAN-2017; Lot# L013204 with expiration 28-JAN-2017, dose and frequency were not reported) orally. The vaccine was stored in the temperature of 33 F (Minimum) and 55F (Maximum) for 12 hours. No adverse event was reported. No product quality complaint was involved. This is one of two cases received from the same source. Additional information has been requested.
vomiting at 11, 14, 21, 29 and 57 hours after injection shaking chills at 16, 21, 29 and 57 hours after injection
A sore upper arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (A sore upper arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (A sore upper arm). At the time of the report, PAIN IN EXTREMITY (A sore upper arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information was not reported. Treatment medications were not provided.   This case was linked to MOD-2021-083707, MOD-2021-083954, US-MODERNATX, INC.-MOD-2021-083954 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Telephone Contact Report received, NNI.; Sender's Comments:  MOD-2021-083707:Husband's case MOD-2021-083954:Husband's-sister's case US-MODERNATX, INC.-MOD-2021-083954:Caller Wife case
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021 at 4:20 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 13-Feb-2021 at 4:20 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of the patient was reported as 54.52.  No concomitant medications were reported.  On 13-Jan-2021, 30 vials were moved to clinic.   The vial was initially moved to the fridge on 09-Feb-2021 and proposed beyond use date was 10-Mar-2021.   On the date of administration, at 09:00 A.M., the temperature recorded was 32 degree Fahrenheit has been reached by the vial. The vial was moved to clinic on 13-Jan-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  The healthcare professional (HCP) reported that, each time a vial was put into a cooler, sometimes there was a period of time of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. The vial was stored in cooler storage during high-pace COVID-19 vaccination clinic at the time of excursion. Temperature recordings were taken using a traceable temperature monitor at every hour.  The vial was not in a frozen state at the time of vaccine administration.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  No treatment information was provided.  The occupation of reporter was reported as clinic manager.   This case was linked to MOD-2022-566976 (Patient Link).
Patient notified me shortly after receiving his vaccine he had onset of "painful tingling throughout body" and erythema of his hands.  Denies chest pain, SOB, difficulty breathing, headaches, dizziness, swelling of lips/tonge/throat, itching or rash. No prior history of any allergic reaction. PMH significant for COVID-19 3/20.   BP 125/88, HR 78, O2 sat 98% RA.  After 45 minutes of observation - patient states he is feeling much better, mild erythema of the hands resolved.  Denies any new symptoms, repeat vitals 122/89, HR 81, O2 sat 97% RA.  Patient states he feels comfortable to go home. Informed patient if he has onset of SOB, chest pain, swelling of lip/tongue/throat, dizziness, or any other symptoms of distress. Reviewed common side effects of vaccine which may have onset tomorrow and supportive measures. Patient verbalized understanding and had no further questions or concerns at this time.
Vaccine administered 1 month too early for routine 1st booster scheduling at 4:44 on 4/14/2022. If dose was intended to be an additional dose for immunocompromised status, there was no record of being immunocompromised. Pt monitored for 15 minutes after administration without incident.
After the 2nd shot I got much more sicker and had a lot more side effects from the first one. I was almost unable to move due to body acts and pain, no medicine (zofran) helped with nausea or vomiting. Lots of things I can't remember since I felt so awful and almost confused to what I was feeling. It was just u like anything I've ever felt before. Long term side effects have been Body chills which started right away and havent stopped and its been almost 2 weeks after.
Initial unsolicited case received from a consumer on 05 Oct 2017. This case involves four-year-old female patient who was vaccinated with a dose of FLUZONE QUADRIVALENT (Batch number, expiry date, dose, dose in series, route and site of administration were not reported) on an unknown date. Patient medical history and concomitant medications were not reported. On an unknown date, one day after the vaccination, patient had a bruised, raised arm that was hot to the touch. Relevant lab tests and corrective treatment were not reported. Outcome of the events were not reported. List of documents held by sender: none.
This spontaneous report as received from a nurse refers to multiple unspecified patients unknown age and gender. No medical history and concurrent conditions were reported. On an unknown dates, the patients were vaccinated with an improperly stored dose of PEDVAXHIB (Lot number L038501, expiry date 16-APR-2018; Lot number L051122, expiry date 12-OCT-2018; Lot number M001813, expiry date 14-OCT-2018) (dosing regimen and frequency unknown). No concomitant medications were reported. No adverse effects were reported. The action taken and the outcome of the events was unknown. There was no product quality complaint reported. This case is linked to case number 1609USA014777 and 1609USA014778 via same reporter link. Additional information has been requested.
This is a 6 month old infant; who the family presents to the pediatrician with complaints of seizure type jerking activity that the parents characterize which is consistent with infantile spasm with flexure spasms of the body, 1-2 days after vaccination.
This spontaneous report was received from a pharmacist via a company representative refers to a female patient of unknown age who was not pregnant. On an unknown date the patient was vaccinated with ZOSTAVAX 0.65 ml, subcutaneous (strength and lot # were not reported). Concomitant therapies included Influenza virus vaccine (unspecified). On an unknown date the patient experienced bump on patient's arm at the injection site after receiving ZOSTAVAX. Patient did not seek medical attention. She did not receive any treatment for the adverse event. The outcome of bump on patient's arm at the injection site was reported as recovered/resolved on unknown date. Additional information has been requested.
stomach issue; pain in the lower abdomen near the colon area/ it seems like they are getting worse/ it seems to get worse right after she eats lunch; extremely sore arm as she couldn't even use her arm for 2 days; nausea; headaches; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach issue), ABDOMINAL PAIN (pain in the lower abdomen near the colon area/ it seems like they are getting worse/ it seems to get worse right after she eats lunch), VACCINATION SITE PAIN (extremely sore arm as she couldn't even use her arm for 2 days), NAUSEA (nausea) and HEADACHE (headaches) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (stomach issue), ABDOMINAL PAIN (pain in the lower abdomen near the colon area/ it seems like they are getting worse/ it seems to get worse right after she eats lunch), VACCINATION SITE PAIN (extremely sore arm as she couldn't even use her arm for 2 days), NAUSEA (nausea) and HEADACHE (headaches). At the time of the report, ABDOMINAL DISCOMFORT (stomach issue), ABDOMINAL PAIN (pain in the lower abdomen near the colon area/ it seems like they are getting worse/ it seems to get worse right after she eats lunch), VACCINATION SITE PAIN (extremely sore arm as she couldn't even use her arm for 2 days), NAUSEA (nausea) and HEADACHE (headaches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test negative: negative negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Non significant follow-up: TCR received, email address, consent to follow-up doctor added
I had a 100.5 fever, with chills, muscle and bone aches, and a headache for two nights after the vaccination.